Vitamins

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Carotenoids
• Phytochemicals
• Healthy Foods
• Dietary Health Benefits
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Cancer Growing evidence suggests that vitamins and micronutrients, especially from foods, may play important roles in the prevention or treatment of certain cancers:

• One study found that the risk of prostate cancer risk dropped as consumption of vegetables high in vitamin C, such as broccoli and bell peppers, rose.
• A diet high in cruciferous vegetables has been found to reduce the risk of kidney cancer; low consumption of cruciferous vegetables increases the risk.

On the other hand, high amounts of folic acid (a B vitamin) may be associated with colorectal cancer, and beta-carotene supplements are associated with increased lung cancer risk in smokers and people exposed to asbestos. Macular Degeneration In 2007, the National Eye Institute recommended that people with intermediate or advanced macular degeneration in one eye take a vitamin formula shown to reduce the risk of macular degeneration in the other eye by 25%. The formula contains vitamin C, vitamin E, beta-carotene, and zinc. - 0 Comments

Weight control and diet

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Biological and Medical Caus...
• Cultural and Emotional Caus...
• Risk Factors
• Complications
• Weight Loss and Maintenance...
• Weight Management
• Medications
• Other Treatments
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Cancer and Weight Control:

• Cancer prevention guidelines from the American Cancer Society stress the importance of maintaining a healthy weight throughout life. A healthy weight is even more important than eating specific healthy foods, when it comes to cancer prevention.

Drug Warning:

• The US Food and Drug Administration (FDA) is warning consumers not to buy a product known as the "Brazilian diet pill." This product is labeled as a dietary supplement, but contains several chemicals found in powerful prescription drugs. - 1 Comment
  Read More ›

Iron

Oct 08, 2008 - Overview

• Overview
• Uses
• Dietary Sources
• Available Forms
• How to Take It
• Precautions
• Possible Interactions
• Supporting Research

HEALTH GUIDE REFERENCE FROM A.D.A.M Overview Iron is an essential mineral that contributes to many important physiologic functions in the body. Much of the iron in the body is attached to hemoglobin molecules in red blood cells, thereby delivering oxygen to all of the tissues. Extra iron is stored in the liver, bone marrow, spleen, and muscles. - 0 Comments

Colon and rectal cancers

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Risk Factors
• Dietary Factors
• Prevention
• Diagnosis
• Staging
• Prognosis
• Surgery
• Medications
• Radiation Treatment
• Follow-up Testing
• Treatment for Metastasized ...
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approval In September 2006, the Food and Drug Administration approved panitumumab (Vectibix) for the treatment of patients with colorectal cancer that has spread to other parts of the body following chemotherapy. Like cetuximab (Ertibux), panitumumab targets the epidermal growth factor receptor (EGFR) on cancer cells. Panitumumab is the first new colorectal cancer drug approved since 2004. - 0 Comments

Diabetes - type 2

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Risk Factors
• Symptoms
• Screening Tests
• Treatment
• Lifestyle Changes
• Medications
• Long-Term Complications
• Emergency Complications
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approvals

• Sitagliptin (Januvia), the first in a new class of diabetes drugs called DPP-4 inhibitors, was approved in 2006.
• Janumet, a 2-in-1 pill that contains both sitagliptin and metformin, was approved in 2007.
• These drugs are taken by mouth and may be more convenient for patients than exenatide (Byetta), a similar drug. DPP-4 inhibitors do not cause weight gain and may pose a lower risk for hypoglycemia than some other diabetes drugs.

Drug Safety Alert Rosiglitazone (Avandia) may significantly increase the risk for heart attack, indicates a review published in the Journal of the American Medical Association. In 2007, a panel of experts from the Food and Drug Administration (FDA) agreed the drug increases the risk of heart attacks -- but concluded it should remain on the market. - 4 Comments

Prostate cancer

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Prognosis
• Risk Factors
• Symptoms
• Conditions with Similar Sym...
• Screening and Diagnosis
• Tests to Determine Severity...
• Treatment
• Treatment Options by Stagin...
• Treatment for Localized Pro...
• Surgery
• Radiation Treatments
• Options if Treatments Fail...
• Other Treatments
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights New Guidelines for Localized Prostate Cancer In 2007, the American Urological Association (AUA) released updated guidelines for treatment of localized prostate cancer. The guidelines recommend that:

• Patients should be classified as low, intermediate, or high risk, depending on their PSA levels, cancer stage, and tumor aggressiveness.
• Doctors need to consider patients’ personal preferences and quality of life concerns as well as their clinical status.
• Standard treatment options include active surveillance (watchful waiting), surgery, or radiation therapy. Initial androgen deprivation therapy (hormone therapy) is seldom recommended for localized prostate cancer.

New Guidelines for Androgen Deprivation Therapy

• The American Society of Clinical Oncology (ASCO) 2007 guidelines recommend that doctors delay androgen deprivation therapy for advanced prostate cancer until patients develop symptoms. - 0 Comments
  Read More ›

High blood pressure

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Diagnosis
• Causes
• Risk Factors
• Complications
• Symptoms
• Treatment
• Lifestyle Changes
• Medications
• Classes of Medications
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approval In 2007, the FDA approved a new type of high blood pressure drug. Aliskiren (Tekturna) blocks renin, a kidney enzyme that is associated with blood pressure regulation. Aliskiren can be taken alone or in combination with other blood pressure drugs, but it should not be used during pregnancy. - 1 Comment